Holen Sie sich die Stockscreener-App
613.28
1.45%
8.32
Schlusskurs vom Vortag:
$604.96
Offen:
$601.05
24-Stunden-Volumen:
12.77M
Relative Volume:
0.84
Marktkapitalisierung:
$1.56T
Einnahmen:
$214.96B
Nettoeinkommen (Verlust:
$70.59B
KGV:
22.30
EPS:
27.5066
Netto-Cashflow:
$48.25B
1W Leistung:
-8.28%
1M Leistung:
+7.11%
6M Leistung:
-0.84%
1J Leistung:
+4.50%
1-Tages-Spanne:
$598.10
$619.95
1-Wochen-Bereich:
$598.10
$620.85
52-Wochen-Spanne:
$520.26
$796.25
Meta Platforms Inc Stock (META) Company Profile
Firmenname
Meta Platforms Inc
Sektor
Telefon
650-543-4800
Adresse
1 META WAY, MENLO PARK
Compare META vs GOOGL, GOOG, SPOT, DASH
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
META
Meta Platforms Inc
|
612.88 | 1.54T | 214.96B | 70.59B | 48.25B | 27.51 |
GOOGL
Alphabet Inc
|
399.14 | 4.71T | 423.17B | 160.21B | 64.43B | 12.78 |
GOOG
Alphabet Inc
|
395.56 | 4.66T | 423.17B | 160.21B | 64.43B | 12.78 |
SPOT
Spotify Technology Sa
|
418.72 | 86.26B | 20.32B | 3.16B | 3.82B | 12.55 |
DASH
Doordash Inc
|
165.57 | 72.39B | 13.72B | 932.00M | 1.83B | 2.1265 |
Meta Platforms Inc Stock (META) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-30 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2026-04-10 | Bestätigt | Wolfe Research | Outperform |
| 2026-04-09 | Bestätigt | Rosenblatt | Buy |
| 2026-04-02 | Herabstufung | Erste Group | Buy → Hold |
| 2026-03-30 | Bestätigt | Morgan Stanley | Overweight |
| 2026-03-05 | Herabstufung | Arete | Buy → Neutral |
| 2026-03-05 | Hochstufung | Erste Group | Hold → Buy |
| 2026-02-23 | Bestätigt | Wells Fargo | Overweight |
| 2026-01-29 | Bestätigt | Canaccord Genuity | Buy |
| 2026-01-29 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2026-01-29 | Bestätigt | Deutsche Bank | Buy |
| 2026-01-29 | Bestätigt | Evercore ISI | Outperform |
| 2026-01-29 | Bestätigt | Guggenheim | Buy |
| 2026-01-29 | Bestätigt | JP Morgan | Overweight |
| 2026-01-29 | Bestätigt | Jefferies | Buy |
| 2026-01-29 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2026-01-29 | Bestätigt | Mizuho | Outperform |
| 2026-01-29 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2026-01-29 | Bestätigt | Morgan Stanley | Overweight |
| 2026-01-29 | Bestätigt | Piper Sandler | Overweight |
| 2026-01-29 | Bestätigt | Pivotal Research Group | Buy |
| 2026-01-29 | Bestätigt | Robert W. Baird | Outperform |
| 2026-01-29 | Bestätigt | Roth Capital | Buy |
| 2026-01-29 | Bestätigt | Stifel | Buy |
| 2026-01-29 | Bestätigt | UBS | Buy |
| 2026-01-29 | Bestätigt | Wedbush | Outperform |
| 2026-01-29 | Bestätigt | Wells Fargo | Overweight |
| 2026-01-29 | Bestätigt | Wolfe Research | Outperform |
| 2026-01-26 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2026-01-26 | Bestätigt | Raymond James | Strong Buy |
| 2026-01-26 | Hochstufung | Rothschild & Co Redburn | Neutral → Buy |
| 2026-01-23 | Bestätigt | Stifel | Buy |
| 2026-01-13 | Bestätigt | TD Cowen | Buy |
| 2026-01-12 | Bestätigt | Wells Fargo | Overweight |
| 2026-01-08 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2026-01-08 | Bestätigt | Guggenheim | Buy |
| 2025-12-04 | Hochstufung | Arete | Neutral → Buy |
| 2025-11-24 | Eingeleitet | BNP Paribas Exane | Outperform |
| 2025-11-10 | Herabstufung | Erste Group | Buy → Hold |
| 2025-10-30 | Bestätigt | Barclays | Overweight |
| 2025-10-30 | Bestätigt | Bernstein | Outperform |
| 2025-10-30 | Bestätigt | BofA Securities | Buy |
| 2025-10-30 | Bestätigt | Citigroup | Buy |
| 2025-10-30 | Bestätigt | JP Morgan | Overweight |
| 2025-10-30 | Bestätigt | Jefferies | Buy |
| 2025-10-30 | Bestätigt | Mizuho | Outperform |
| 2025-10-30 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2025-10-30 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-10-30 | Bestätigt | Piper Sandler | Overweight |
| 2025-10-30 | Bestätigt | Stifel | Buy |
| 2025-10-30 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2025-10-20 | Bestätigt | Oppenheimer | Outperform |
| 2025-10-07 | Bestätigt | Wells Fargo | Overweight |
| 2025-09-30 | Eingeleitet | Mizuho | Outperform |
| 2025-07-31 | Bestätigt | BMO Capital Markets | Market Perform |
| 2025-07-31 | Bestätigt | Bernstein | Outperform |
| 2025-07-31 | Bestätigt | BofA Securities | Buy |
| 2025-07-31 | Bestätigt | Citigroup | Buy |
| 2025-07-31 | Bestätigt | Citizens JMP | Mkt Outperform |
| 2025-07-31 | Bestätigt | JP Morgan | Overweight |
| 2025-07-31 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2025-07-31 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2025-07-31 | Bestätigt | Morgan Stanley | Overweight |
| 2025-07-31 | Bestätigt | Oppenheimer | Outperform |
| 2025-07-31 | Bestätigt | Pivotal Research Group | Buy |
| 2025-07-31 | Bestätigt | TD Cowen | Buy |
| 2025-07-31 | Bestätigt | UBS | Buy |
| 2025-07-31 | Bestätigt | Wedbush | Outperform |
| 2025-07-31 | Bestätigt | Wells Fargo | Overweight |
| 2025-07-28 | Bestätigt | Guggenheim | Buy |
| 2025-07-16 | Bestätigt | Canaccord Genuity | Buy |
| 2025-07-03 | Hochstufung | Needham | Underperform → Hold |
| 2025-06-26 | Bestätigt | UBS | Buy |
| 2025-06-24 | Bestätigt | Citigroup | Buy |
| 2025-05-01 | Bestätigt | BofA Securities | Buy |
| 2025-05-01 | Bestätigt | Citigroup | Buy |
| 2025-05-01 | Bestätigt | Evercore ISI | Outperform |
| 2025-05-01 | Bestätigt | Goldman | Buy |
| 2025-05-01 | Bestätigt | Guggenheim | Buy |
| 2025-05-01 | Bestätigt | JP Morgan | Overweight |
| 2025-05-01 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2025-05-01 | Bestätigt | MoffettNathanson | Buy |
| 2025-05-01 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2025-05-01 | Bestätigt | Morgan Stanley | Overweight |
| 2025-05-01 | Bestätigt | Oppenheimer | Outperform |
| 2025-05-01 | Bestätigt | Piper Sandler | Overweight |
| 2025-05-01 | Bestätigt | Pivotal Research Group | Buy |
| 2025-05-01 | Bestätigt | Raymond James | Strong Buy |
| 2025-05-01 | Bestätigt | Rosenblatt | Buy |
| 2025-05-01 | Bestätigt | Roth Capital | Buy |
| 2025-05-01 | Bestätigt | Stifel | Buy |
| 2025-05-01 | Bestätigt | Truist | Buy |
| 2025-05-01 | Bestätigt | UBS | Buy |
| 2025-05-01 | Bestätigt | Wedbush | Outperform |
| 2025-04-14 | Bestätigt | Citigroup | Buy |
| 2025-04-10 | Bestätigt | Piper Sandler | Overweight |
| 2025-01-30 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2025-01-23 | Bestätigt | BofA Securities | Buy |
| 2025-01-22 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2025-01-06 | Bestätigt | Jefferies | Buy |
| 2025-01-03 | Bestätigt | Wolfe Research | Outperform |
| 2024-10-31 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2024-10-31 | Bestätigt | Pivotal Research Group | Buy |
| 2024-10-11 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-09 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2024-10-01 | Eingeleitet | Pivotal Research Group | Buy |
| 2024-09-30 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2024-09-10 | Eingeleitet | DA Davidson | Buy |
| 2024-09-05 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-08-01 | Bestätigt | BofA Securities | Buy |
| 2024-07-19 | Bestätigt | Oppenheimer | Outperform |
| 2024-07-16 | Eingeleitet | Wolfe Research | Outperform |
| 2024-07-10 | Bestätigt | TD Cowen | Buy |
| 2024-07-08 | Bestätigt | Wells Fargo | Overweight |
| 2024-07-01 | Bestätigt | Raymond James | Strong Buy |
| 2024-06-12 | Bestätigt | BMO Capital Markets | Market Perform |
| 2024-05-02 | Eingeleitet | Exane BNP Paribas | Underperform |
| 2024-04-25 | Bestätigt | Oppenheimer | Outperform |
| 2024-04-15 | Bestätigt | Citigroup | Buy |
| 2024-04-11 | Bestätigt | Piper Sandler | Overweight |
| 2024-04-08 | Bestätigt | Oppenheimer | Outperform |
| 2024-04-04 | Bestätigt | Jefferies | Buy |
| 2024-02-02 | Bestätigt | Guggenheim | Buy |
| 2024-02-02 | Bestätigt | JMP Securities | Mkt Outperform |
| 2024-02-02 | Bestätigt | JP Morgan | Overweight |
| 2024-02-02 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2024-02-02 | Bestätigt | Mizuho | Buy |
| 2024-02-02 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2024-02-02 | Bestätigt | Morgan Stanley | Overweight |
| 2024-02-02 | Bestätigt | Oppenheimer | Outperform |
| 2024-02-02 | Bestätigt | Piper Sandler | Overweight |
| 2024-02-02 | Bestätigt | ROTH MKM | Buy |
| 2024-02-02 | Bestätigt | Raymond James | Strong Buy |
| 2024-02-02 | Bestätigt | Robert W. Baird | Outperform |
| 2024-02-02 | Bestätigt | Seaport Research Partners | Buy |
| 2024-02-02 | Bestätigt | Stifel | Buy |
| 2024-02-02 | Bestätigt | Susquehanna | Positive |
| 2024-02-02 | Bestätigt | TD Cowen | Outperform |
| 2024-02-02 | Bestätigt | UBS | Buy |
| 2024-02-02 | Bestätigt | Wedbush | Outperform |
| 2024-02-02 | Bestätigt | Wells Fargo | Overweight |
| 2024-02-02 | Bestätigt | Wolfe Research | Outperform |
| 2024-01-23 | Bestätigt | Citigroup | Buy |
| 2024-01-17 | Bestätigt | Piper Sandler | Overweight |
| 2024-01-17 | Bestätigt | Wells Fargo | Overweight |
| 2024-01-09 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2023-12-20 | Fortgesetzt | Raymond James | Strong Buy |
| 2023-10-24 | Eingeleitet | Seaport Research Partners | Buy |
| 2023-08-22 | Eingeleitet | Wedbush | Outperform |
| 2023-08-01 | Bestätigt | Argus | Buy |
| 2023-07-28 | Hochstufung | China Renaissance | Hold → Buy |
| 2023-07-27 | Hochstufung | HSBC Securities | Reduce → Hold |
| 2023-07-27 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-07-25 | Bestätigt | Mizuho | Buy |
| 2023-07-25 | Hochstufung | New Street | Neutral → Buy |
| 2023-07-19 | Bestätigt | Jefferies | Buy |
| 2023-07-19 | Bestätigt | Truist | Buy |
| 2023-07-17 | Bestätigt | Credit Suisse | Outperform |
| 2023-07-17 | Bestätigt | Goldman | Buy |
| 2023-07-17 | Bestätigt | JMP Securities | Mkt Outperform |
| 2023-07-13 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-07-12 | Bestätigt | Deutsche Bank | Buy |
| 2023-06-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-05-15 | Hochstufung | Loop Capital | Hold → Buy |
| 2023-04-27 | Bestätigt | Credit Suisse | Outperform |
| 2023-04-27 | Bestätigt | Deutsche Bank | Buy |
| 2023-04-27 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-27 | Bestätigt | Goldman | Buy |
| 2023-04-27 | Bestätigt | Guggenheim | Buy |
| 2023-04-27 | Bestätigt | JMP Securities | Mkt Outperform |
| 2023-04-27 | Bestätigt | JP Morgan | Overweight |
| 2023-04-27 | Bestätigt | Mizuho | Buy |
| 2023-04-27 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2023-04-27 | Bestätigt | Morgan Stanley | Overweight |
| 2023-04-27 | Bestätigt | Oppenheimer | Outperform |
| 2023-04-27 | Bestätigt | Piper Sandler | Overweight |
| 2023-04-27 | Bestätigt | RBC Capital Mkts | Outperform |
| 2023-04-27 | Bestätigt | Raymond James | Outperform |
| 2023-04-27 | Bestätigt | Robert W. Baird | Outperform |
| 2023-04-27 | Bestätigt | Rosenblatt | Buy |
| 2023-04-27 | Bestätigt | Stifel | Buy |
| 2023-04-27 | Bestätigt | TD Cowen | Market Perform |
| 2023-04-27 | Bestätigt | Truist | Buy |
| 2023-04-27 | Bestätigt | Wolfe Research | Outperform |
Alle ansehen
Meta Platforms Inc Aktie (META) Neueste Nachrichten
New Mexico proposes $3.7bn fine for Meta and sweeping changes to its social platforms - The Guardian
Virtus Wealth Solutions LLC Sells 25,356 Shares of Meta Platforms, Inc. $META - MarketBeat
Ireland Moves Deeper into DSA Oversight with New Meta Dark Patterns Probe - Tech Policy Press
Meta suggets total shutdown in New Mexico - KOAT
After Earnings, Is Meta Stock a Buy, a Sell, or Fairly Valued? - Morningstar
Meta Stock Price Forecast 2026-2030: Can META Hit $1,000? - TradingKey
ProVise Management Group LLC Has $15.70 Million Stock Holdings in Meta Platforms, Inc. $META - MarketBeat
TBH Global Asset Management LLC Grows Stock Position in Meta Platforms, Inc. $META - MarketBeat
Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management Lowers Stock Holdings in Meta Platforms, Inc. $META - MarketBeat
Meta Platforms, Inc. $META Shares Bought by Rakuten Securities Inc. - MarketBeat
Meta Platforms, Inc. $META Stock Position Increased by Generali Investments Management Co LLC - MarketBeat
Golden Reserve Retirement LLC Invests $939,000 in Meta Platforms, Inc. $META - MarketBeat
China Universal Asset Management Co. Ltd. Buys 5,905 Shares of Meta Platforms, Inc. $META - MarketBeat
Copeland Capital Management LLC Cuts Stock Position in Meta Platforms, Inc. $META - MarketBeat
Cypress Asset Management Inc. TX Acquires 1,307 Shares of Meta Platforms, Inc. $META - MarketBeat
Focused Wealth Management Inc Trims Stake in Meta Platforms, Inc. $META - MarketBeat
Meta Develops OpenClaw-Inspired AI Assistant to Operate Users’ Computers - bloomingbit
Thinking of Buying Pinterest? Stop and Do This Instead. - The Motley Fool
Publishers sue Meta, claiming it violated copyrights in training AI with their books - The Washington Post
Meta’s Texas AI Build And Space Solar Deal Reshape Investment View - Yahoo Finance
Meta Platforms, Inc. (META.US) Reportedly Developing OpenClaw-like Intelligent Assistant Tool - AASTOCKS.com
Meta director Peggy Alford sells $251,342 in stock - Investing.com
Meta Is Building an AI Agent Called ‘Hatch’ and an AI Shopping Tool in Instagram - The Information
Scams starting on Meta social media sites soar, so a watchdog sued - Detroit Free Press
Even Laying Off 100% of Its Workers Won't Recoup This Company's AI Costs - The Motley Fool
Major publishers sue Meta for copyright infringement over AI training - Maryland Daily Record
Meta plans advanced ‘agentic’ AI assistant for consumers - Financial Times
Pinterest CEO Says Social Media Companies Should Compete on Safety as Meta Faces Another Trial - inc.com
Korean court rules in favor of Meta in closely watched corporate tax dispute - KED Global
Meta Fights EU on WhatsApp AI Access as Costs Outpace Revenue - Gotrade
Meta’s copyright infringement was authorized by Zuckerberg, publishers allege - The Globe and Mail
Meta Hit With Patent Suit Over Metadata Extraction Technology - Bloomberg Law News
Ireland probes Meta's Instagram, Facebook over EU manipulation concerns - Reuters
New Mexico Seeks Child Safety Restrictions on Meta Apps and Algorithms in Trial’s 2nd Phase - First Amendment Watch
Meta and Zuckerberg sued by publishers over ‘massive’ copyright infringement - Financial Times
Parents on Instagram, Facebook: Meta wants to talk to you about your teen - Mashable
Ireland probes Facebook and Instagram’s recommender systems - Euractiv
Meta faces maximum €20bn fine from Irish regulator over ‘dark patterns’ from recommender systems - The Irish Independent
Why Meta's head of Threads thinks it's great if users move to DMs and 'lurk' in the feed - Business Insider
Publishers Sue Meta for Allegedly Using Copyrighted Works to Train AI - WSJ
Publishers File Lawsuit Against Meta, Mark Zuckerberg - Publishers Weekly
As Meta Platforms Buys Assured Robot Intelligence, META Stock Becomes a Bet on Humanoids - Barchart.com
Tucson pediatricians warn of social media harm as Meta faces legal battles - KOLD
Why Meta Stock Is Objectively Cheap at Current Levels - Barchart
Meta says it will use AI technology to enforce age restrictions on platforms - Baltimore Sun
Tesla, Meta, Microsoft Investors May Need A 'Self-Destruct' Switch, Not Blind Faith - Benzinga
Meta Platforms (META) – Among the 10 Best Blue Chip Stocks to Invest in According to Billionaires - Yahoo Finance Singapore
Meta Drops Post-Earnings, Is It Time to Buy - Gotrade
Meta's AI Fear Creates Rare Blue-Chip Mispricing (NASDAQ:META) - Seeking Alpha
Meta says it will use artificial intelligence to enforce age restrictions on platforms - WPDE
META stock — $606.80 · -0.60% · $1.55T cap - Techi
Finanzdaten der Meta Platforms Inc-Aktie (META)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.28%
5.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):